Agus Yudawijaya
Faculty Of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

The Relationship Between Body Mass Index (BMI) and Pain Intensity in Patients With Lumbar Nucleus Pulposus Hernia (HNP) Patria Adri Wibhawa; Tranggono Yudo Utomo; Agus Yudawijaya; Gabriella Natasha Levina Sihombing
International Journal of Health and Pharmaceutical (IJHP) Vol. 6 No. 2 (2026): May 2026
Publisher : CV. Inara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51601/ijhp.v6i2.530

Abstract

Lumbar Herniated Nucleus Pulposus (HNP) is one of the main causes of low back pain that can reduce the quality of life of sufferers. Risk factor that affect the intensity of pain in HNP patients include body mass index (BMI). An increase in BMI can cause additional mechanical stress on the lumbar spine, alter posture, and exacerbate pain. The purpose of this study was to determine the relationship between BMI and pain intensity in patients with lumbar HNP at Budhi Asih General Hospital. This study used an analytical observational research method with a cross-sectional approach. The study sample consisted of 54 patients. BMI data obtained from measuring the patients' height and weight were classified according to WHO categories, while pain intensity was measured using the Visual Analog Scale (VAS) instrument. Data analysis using the Chi-Square test showed a significant relationship between BMI and pain intensity in patients with lumbar HNP (P < 0.029). These findings indicate that obesity increases the mechanical load on the lumbar spine, thereby exacerbating pain in HNP patients. In conclusion, there is a significant relationship between BMI and pain intensity in lumbar HNP patients. Therefore, weight control through a healthy lifestyle and appropriate rehabilitation programs is expected to reduce pain intensity and improve patients' quality of life.
Serum Electrolyte and Blood Lipid Profile in Stroke Patients Tranggono Yudo Utomo; Meriyanti Wimny Gwijangge; Agus Yudawijaya
Indonesian Journal of Global Health Research Vol 7 No 5 (2025): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v7i5.6855

Abstract

Stroke is a leading cause of death and disability worldwide, including in Indonesia. While vascular factors are the primary cause, metabolic components such as serum electrolytes and blood lipids also play a significant role in the onset and progression of stroke. Imbalances in sodium, potassium, and chloride, as well as abnormalities in cholesterol and triglyceride levels, can influence both stroke risk and prognosis. Understanding these biochemical profiles in stroke patients is essential for improving clinical outcomes. This study aims to analyze the profile of serum electrolytes and blood lipids in stroke patients treated at Dr. Chasbullah Abdulmajid Hospital, Bekasi City, during the period December 2024 to March 2025. Stroke is one of the leading causes of morbidity and mortality worldwide, which is known to occur due to vascular factors. Metabolic factors such as serum electrolytes and blood lipids can play an important role in the pathogenesis and prognosis of stroke. Using a descriptive design, patient medical record data were collected and analyzed, which were then processed univariately, with a focus on serum electrolyte profiles, including sodium, potassium, and chloride, as well as blood lipid profiles, such as total cholesterol, LDL, and HDL. The results showed that the characteristics of stroke patients treated at Dr. Chasbullah Abdulmajid Hospital, Bekasi City, during the period from December 2024 to March 2025, differed only by gender, with 46 patients (50.5%) being male and 45 patients (49.5%) being female. The most common comorbid history in stroke patients was hypertension, totaling 53 people (58.3%), followed by diabetes mellitus, totaling 26 (28.6%). The largest electrolyte imbalance disorder was hypokalemia in 43 people (47.3%), followed by hyponatremia in 35 people (38.5%) and hyperchloremia in 23 people (25.3%). The majority of patients had low HDL levels, with 46 people (50.5%), 27 people (29.7%) having increased triglyceride levels, and 20 people (22.0%) having quite high cholesterol levels. These findings are expected to provide important insights for clinical management and prevention of stroke in the future.
The Role of Cytoflavin as Adjuvant Therapy in Acute Stroke in Evolution: A Case Report at Dr. Chasbullah Abdul Majid Regional Hospital, Bekasi City Tranggono Yudo Utomo; Daniel Jhosias Samosir; Agus Yudawijaya
Contagion: Scientific Periodical Journal of Public Health and Coastal Health Vol 8, No 3 (2026): Contagion
Publisher : Universitas Islam Negeri Sumatera Utara, Medan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30829/contagion.v8i3.28706

Abstract

Ischemic stroke results from reduced cerebral blood flow due to vascular occlusion, while Acute Stroke in Evolution (ASE) is characterized by progressive neurological deterioration during the acute phase. Cytoflavin has been proposed as an adjuvant neuroprotective therapy because of its potential to support cellular metabolism and tolerance to hypoxia; however, clinical evidence regarding its role in ASE remains limited, particularly in patients with multiple vascular risk factors. To document serial changes in neurological deficit, assessed using the National Institutes of Health Stroke Scale (NIHSS), and the safety of Cytoflavin as an adjuvant therapy in a single case of ASE with multiple risk factors. This was a prospective single-case report of a 38-year-old man with lacunar ischemic stroke managed at Dr. Chasbullah Abdul Majid Regional Hospital, Bekasi City. Clinical progression was evaluated through serial neurological examinations, NIHSS assessments, and head computed tomography (CT). The patient presented with sudden right-sided weakness, dysarthria, and facial deviation. His vascular risk factors included uncontrolled diabetes mellitus, hypertension, obesity, dyslipidemia, and smoking. The initial NIHSS score was 5, and head CT demonstrated a left basal ganglia lacunar infarction. On day four, neurological deficits worsened, with right-sided motor strength decreasing to 2/5 and the NIHSS score increasing to 12, consistent with ASE. Intravenous Cytoflavin 500 mg in 100 mL 0.9% NaCl three times daily was administered for 10 days. Neurological improvement began on day six. By day ten, motor strength improved to 5−, the patient was able to ambulate with mild hemiparesis, and the NIHSS score decreased to 4. The neurological improvement was temporally associated with the administration of Cytoflavin and comprehensive supportive management. No significant safety concerns were observed during treatment. In this single uncontrolled case of ASE, administration of Cytoflavin as an adjuvant therapy was temporally associated with improvement in neurological deficits, reflected by a reduction in NIHSS from 12 to 4 over 10 days. However, no causal inference can be drawn from a single uncontrolled case. These findings highlight the need for randomized controlled trials to determine the efficacy and safety of Cytoflavin as an adjuvant neuroprotective therapy in patients with ASE. Keywords: Cytoflavin, Stroke Iskemik, NIHSS, Infark Lacunar